Since PTEN acts as a potent inhibitor of the insulin cascade, these data suggest a possible role of insulin signaling hyperactivation in MSL pathogenesis, as observed in other types of AT overgrowth [15]. The gene discussed is PTEN; the disease is multiple symmetric lipomatosis.